Literature DB >> 11576780

Optimized conditions of bio-mimetic artificial membrane permeation assay.

K Sugano1, H Hamada, M Machida, H Ushio, K Saitoh, K Terada.   

Abstract

Effects of pH and co-solvents on the bio-mimetic artificial membrane permeation assay were investigated to determine the optimal conditions for the prediction of oral absorption. The permeability (P(am)) of 33 structurally diverse drugs to the PC/PE/PS/PI/CHO/1,7-octadiene membrane system (bio-mimetic lipid (BML) membrane) was measured at pH 5.5, 6.5, and 7.4. The pH dependence of P(am) was in accordance with the pH partition theory. The better prediction of oral absorption (fraction of a dose absorbed) was shown under the pH 5.5 condition (r=0.866, n=25) and/or pH 6.5 (r=0.865, n=28), rather than pH 7.4 (r=0.767, n=24). Then, the appropriate conditions for determining the permeability of poorly soluble compounds were examined. Dimethysulfoxide (DMSO), ethanol (EtOH) and polyoxyethyleneglycol 400 (PEG 400) were added up to 30% to the transport medium as solubilizers. DMSO, EtOH and PEG 400 decreased P(am) of hydrocortisone and propranolol. For example, DMSO (30%) decreased P(am) of hydrocortisone by 60% and by 70% in the case of propranolol. DMSO and PEG 400 also decreased P(am) of ketoprofen. In contrast, EtOH produced an opposite effect on permeability, i.e. an increased P(am) of ketoprofen. Therefore, the high concentration of these co-solvents could lead to the under- or overestimation of drug permeability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576780     DOI: 10.1016/s0378-5173(01)00845-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Applications of human pharmacokinetic prediction in first-in-human dose estimation.

Authors:  Peng Zou; Yanke Yu; Nan Zheng; Yongsheng Yang; Hayley J Paholak; Lawrence X Yu; Duxin Sun
Journal:  AAPS J       Date:  2012-03-10       Impact factor: 4.009

2.  Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption.

Authors:  Rajeshwar P Verma; Corwin Hansch; Cynthia D Selassie
Journal:  J Comput Aided Mol Des       Date:  2007-01-26       Impact factor: 3.686

3.  Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology.

Authors:  Dmitry Sakharov; Diana Maltseva; Evgeny Knyazev; Sergey Nikulin; Andrey Poloznikov; Sergey Shilin; Ancha Baranova; Irina Tsypina; Alexander Tonevitsky
Journal:  BMC Syst Biol       Date:  2019-03-05

4.  In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil.

Authors:  Matej Velický; Dan F Bradley; Kin Y Tam; Robert A W Dryfe
Journal:  Pharm Res       Date:  2010-05-07       Impact factor: 4.200

5.  Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans.

Authors:  Ryoichi Saitoh; Kiyohiko Sugano; Noriyuki Takata; Tatsuhiko Tachibana; Atsuko Higashida; Yoshiaki Nabuchi; Yoshinori Aso
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

6.  A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.

Authors:  Hui Yu; Qi Wang; Ying Sun; Ming Shen; He Li; Yourong Duan
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

7.  Prediction of Passive Membrane Permeability by Semi-Empirical Method Considering Viscous and Inertial Resistances and Different Rates of Conformational Change and Diffusion.

Authors:  Yoshifumi Fukunishi; Tadaaki Mashimo; Takashi Kurosawa; Yoshinori Wakabayashi; Hironori K Nakamura; Koh Takeuchi
Journal:  Mol Inform       Date:  2019-10-14       Impact factor: 3.353

8.  In vitro pH dependent passive transport of ketoprofen and metformin.

Authors:  Alisa Elezović; Amina Marić; Amila Biščević; Jasmina Hadžiabdić; Selma Škrbo; Selma Špirtović-Halilović; Ognjenka Rahić; Edina Vranić; Amar Elezović
Journal:  ADMET DMPK       Date:  2020-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.